BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15906349)

  • 21. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
    Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
    Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
    Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
    Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma.
    Hirata H; Naito K; Yoshihiro S; Matsuyama H; Suehiro Y; Hinoda Y
    Int J Cancer; 2003 Sep; 106(3):372-4. PubMed ID: 12845675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association of ABCG2 gene C421A polymorphism and susceptibility of primary gout in Han Chinese males].
    Li FG; Chu Y; Meng DM; Tong YW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):683-5. PubMed ID: 22161105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
    Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.
    Kobayashi D; Ieiri I; Hirota T; Takane H; Maegawa S; Kigawa J; Suzuki H; Nanba E; Oshimura M; Terakawa N; Otsubo K; Mine K; Sugiyama Y
    Drug Metab Dispos; 2005 Jan; 33(1):94-101. PubMed ID: 15475413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABCG2/BCRP dysfunction as a major cause of gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.
    Audenet F; Cancel-Tassin G; Bigot P; Audouin M; Gaffory C; Ondet V; Thibault F; Auribault K; Gazut S; Benhabiles N; Azzouzi AR; Méjean A; Rouprêt M; Cussenot O
    J Urol; 2014 Feb; 191(2):487-92. PubMed ID: 23911636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
    Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
    Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of the human variants of breast cancer resistance protein: I206L, N590Y, and D620N.
    Vethanayagam RR; Wang H; Gupta A; Zhang Y; Lewis F; Unadkat JD; Mao Q
    Drug Metab Dispos; 2005 Jun; 33(6):697-705. PubMed ID: 15743976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.
    Zhang W; Yu BN; He YJ; Fan L; Li Q; Liu ZQ; Wang A; Liu YL; Tan ZR; Fen-Jiang ; Huang YF; Zhou HH
    Clin Chim Acta; 2006 Nov; 373(1-2):99-103. PubMed ID: 16784736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ABCG2 gene Q141K polymorphism contributes to an increased risk of gout: a meta-analysis of 2185 cases.
    Qiu Y; Liu H; Qing Y; Yang M; Tan X; Zhao M; Lin M; Zhou J
    Mod Rheumatol; 2014 Sep; 24(5):829-34. PubMed ID: 24499401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Analysis of the ABCG2 c.421C>A Polymorphism Effect on In Vivo Transport Activity of Breast Cancer Resistance Protein (BCRP) Using an Intestinal Absorption Model.
    Tanaka Y; Kitamura Y; Maeda K; Sugiyama Y
    J Pharm Sci; 2015 Sep; 104(9):3039-48. PubMed ID: 25639366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
    Mizuarai S; Aozasa N; Kotani H
    Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.
    Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C
    Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
    Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
    Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.